rs2172749
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000508941.5(IL7R):c.-139-870G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.704 in 152,056 control chromosomes in the GnomAD database, including 38,842 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.70 ( 38842 hom., cov: 32)
Consequence
IL7R
ENST00000508941.5 intron
ENST00000508941.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.102
Publications
11 publications found
Genes affected
IL7R (HGNC:6024): (interleukin 7 receptor) The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
IL7R Gene-Disease associations (from GenCC):
- immunodeficiency 104Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- Omenn syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.864 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
Frequencies
GnomAD3 genomes AF: 0.704 AC: 106995AN: 151938Hom.: 38818 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
106995
AN:
151938
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.704 AC: 107067AN: 152056Hom.: 38842 Cov.: 32 AF XY: 0.698 AC XY: 51863AN XY: 74306 show subpopulations
GnomAD4 genome
AF:
AC:
107067
AN:
152056
Hom.:
Cov.:
32
AF XY:
AC XY:
51863
AN XY:
74306
show subpopulations
African (AFR)
AF:
AC:
36165
AN:
41510
American (AMR)
AF:
AC:
8751
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
2210
AN:
3468
East Asian (EAS)
AF:
AC:
2149
AN:
5164
South Asian (SAS)
AF:
AC:
2480
AN:
4810
European-Finnish (FIN)
AF:
AC:
7499
AN:
10562
Middle Eastern (MID)
AF:
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
AC:
45483
AN:
67960
Other (OTH)
AF:
AC:
1419
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1521
3042
4563
6084
7605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.